These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21263139)

  • 1. Child development following in utero exposure: levetiracetam vs sodium valproate.
    Shallcross R; Bromley RL; Irwin B; Bonnett LJ; Morrow J; Baker GA; ;
    Neurology; 2011 Jan; 76(4):383-9. PubMed ID: 21263139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.
    Shallcross R; Bromley RL; Cheyne CP; García-Fiñana M; Irwin B; Morrow J; Baker GA; ;
    Neurology; 2014 Jan; 82(3):213-21. PubMed ID: 24401687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol.
    Stjerna S; Huber-Mollema Y; Tomson T; Perucca E; Battino D; Craig J; Sabers A; Thomas S; Vajda F; Gaily E
    Epilepsy Behav; 2024 Oct; 159():110024. PubMed ID: 39217754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy.
    Huber-Mollema Y; Oort FJ; Lindhout D; Rodenburg R
    Epilepsia; 2019 Jun; 60(6):1069-1082. PubMed ID: 31166022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate.
    Bromley RL; Calderbank R; Cheyne CP; Rooney C; Trayner P; Clayton-Smith J; García-Fiñana M; Irwin B; Morrow JI; Shallcross R; Baker GA;
    Neurology; 2016 Nov; 87(18):1943-1953. PubMed ID: 27581218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive functions in children exposed to antiepileptic drugs in utero - Study in Georgia.
    Kasradze S; Gogatishvili N; Lomidze G; Ediberidze T; Lazariashvili M; Khomeriki K; Mamukadze S; Metreveli M; Gagoshidze T; Tatishvili N; Tomson T
    Epilepsy Behav; 2017 Jan; 66():105-112. PubMed ID: 28038386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.
    Cummings C; Stewart M; Stevenson M; Morrow J; Nelson J
    Arch Dis Child; 2011 Jul; 96(7):643-7. PubMed ID: 21415043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.
    Meador KJ; Baker GA; Browning N; Clayton-Smith J; Combs-Cantrell DT; Cohen M; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    N Engl J Med; 2009 Apr; 360(16):1597-605. PubMed ID: 19369666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of in utero exposure to valproate or levetiracetam on the seizures and newborn histopathology of genetic absence epilepsy rats.
    Can Kantarci B; Sanli A; Gavas S; Toplu A; Nur Turgan Asik Z; Tugce Cilingir-Kaya O; Gulcebi Idrizoglu M; Ercan F; Onat F
    Neurosci Lett; 2022 Apr; 776():136574. PubMed ID: 35271996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiepileptic drugs on reproductive endocrine function, sexual function and sperm parameters in Chinese Han men with epilepsy.
    Xiaotian X; Hengzhong Z; Yao X; Zhipan Z; Daoliang X; Yumei W
    J Clin Neurosci; 2013 Nov; 20(11):1492-7. PubMed ID: 23938015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam use during pregnancy in women with epilepsy: Preliminary observations from a tertiary care center in Northern India.
    Bansal R; Suri V; Chopra S; Aggarwal N; Sikka P; Saha SC; Goyal MK; Kumar P
    Indian J Pharmacol; 2018; 50(1):39-43. PubMed ID: 29861526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposure.
    Huber-Mollema Y; van Iterson L; Oort FJ; Lindhout D; Rodenburg R
    J Neurol; 2020 Jun; 267(6):1724-1736. PubMed ID: 32112258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
    Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study.
    Bosak M; Słowik A; Turaj W
    Epilepsy Behav; 2019 Sep; 98(Pt A):1-5. PubMed ID: 31299525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of anti-epileptic drugs-an internet study.
    Wieshmann UC; Baker G
    Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.
    Meador KJ; Baker GA; Browning N; Cohen MJ; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    Lancet Neurol; 2013 Mar; 12(3):244-52. PubMed ID: 23352199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
    Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
    BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study.
    Baker GA; Bromley RL; Briggs M; Cheyne CP; Cohen MJ; García-Fiñana M; Gummery A; Kneen R; Loring DW; Mawer G; Meador KJ; Shallcross R; Clayton-Smith J;
    Neurology; 2015 Jan; 84(4):382-90. PubMed ID: 25540307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
    Christensen J; Grønborg TK; Sørensen MJ; Schendel D; Parner ET; Pedersen LH; Vestergaard M
    JAMA; 2013 Apr; 309(16):1696-703. PubMed ID: 23613074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.